Cavan M. Redmond
CIK 1420120 · Chief Executive Officer · last filed 2022-07-19
Cavan M. Redmond is a Chief Executive Officer who has filed 27 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for OCX, was dated Jul 19, 2022. Across all open-market trades the lifetime net is +$47.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.84M
6
27
$47.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 120,863 | $3.20 | $386.8K | $47.6K | 10 | 2022-07-19 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | — | — | — | $0 | 1 | 2018-07-03 |
| WebMD Health Corp. (WBMD) Delisted | Chief Executive Officer | 45,000 | — | — | $0 | 2 | 2012-06-28 |
| PFE | Group President | 184,840 | $26.21 | $4.84M | $0 | 7 | 2012-06-01 |
| WYETH (WYEp.CL) Delisted | Pres., Wyeth Consumer Health. | 66,701 | — | — | $0 | 1 | 2009-04-29 |
| WYETH (WYEp) Delisted | Pres., Wyeth Consumer Health. | 69,651 | — | — | $0 | 5 | 2009-03-03 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Exer (M) | +10,000 | $0 | EDGAR |
| 2022-03-16 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +40,000 | $47.6K | EDGAR |
| 2021-06-28 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-15 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +18,416 | $0 | EDGAR |
| 2020-06-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-04 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-31 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +52,447 | $0 | EDGAR |
| 2018-07-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |